Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
10/2010
10/05/2010US7807664 4,4-difluoro-1,2,3,4-tetrahydro-5H-1-benzazepine derivative or salt thereof
10/05/2010US7807659 5-Fluoro-4-oxo-3-[1-(substituted-carbonyl)-2-piperidinecarboxamido]-pentanoic acid derivatives such as [3S/R (2S)]-5-Fluoro-4-oxo-3-[1-(2-phenyl-thiazole-4-carbonyl)-2-piperidinecarboxamido]-pentanoic acid, used for the treatment of bone disorders, inflammatory, autoimmune and degenerative diseases
10/05/2010US7807656 Pharmaceutical applications of hyaluronic acid preparations
10/05/2010US7807191 Apparatus and methods for preventing or treating failure of hemodialysis vascular access and other vascular grafts
10/05/2010US7807176 Polypeptide promoting vascular endothelial cell growth
10/05/2010US7807170 Modulating an immune response in a subject by administering an effective amount of a lymphocyte differentiation factor; antiinflammatory agents
10/05/2010US7806924 Implantable structures for local vascular delivery of cladribine in combination with rapamycin for restenosis
10/05/2010CA2400479C Platelet adp receptor inhibitors
10/05/2010CA2391161C Pharmaceutical combinations comprising a p2t receptor antagonist and an anti-thrombotic agent
10/05/2010CA2367138C Anti-inflammatory uses of manzamines
09/2010
09/30/2010WO2010111702A1 Methods for preventing and treating angioedema
09/30/2010WO2010110908A2 Transdermal venous access locking solution
09/30/2010WO2010110479A1 Activator for peroxisome proliferator-activated receptor
09/30/2010WO2010110380A1 Fused piperidine compound and pharmaceutical agent comprising same
09/30/2010WO2010068710A3 Kinase inhibitor compounds
09/30/2010US20100249747 Transdermal venous access locking solution
09/30/2010US20100249218 Method to inhibit cell growth using oligonucleotides
09/30/2010US20100249217 Modulators of pharmacological agents
09/30/2010US20100249189 Nitric oxide donor compounds
09/30/2010US20100249159 Rho-kinase inhibitors
09/30/2010US20100249118 Compounds and methods for kinase modulation, and indications therefor
09/30/2010US20100249092 Heteroaryl compounds and uses thereof
09/30/2010US20100249081 Compositions and methods for treatment of renal disease
09/30/2010US20100249033 Polymer factor ix moiety conjugates
09/30/2010US20100249027 Crf conjugates with extended half-lives
09/30/2010US20100247681 Nitrite and nitrite-metheme therapy to detoxify stroma-free hemoglobin based blood substitutes
09/30/2010US20100247676 Compositions and methods for treatment of hemorrhage
09/30/2010US20100247661 Method of Drug Formulation Based on Increasing the Affinity of Active Agents for Crystalline Microparticle Surfaces
09/30/2010US20100247518 Modified proteins, designer toxins, and methods of making thereof
09/30/2010US20100247506 Formation of stable submicron peptide or protein particles by thin film freezing
09/30/2010US20100247482 Tight junction modulator peptides for enhanced mucosal delivery of therapeutic compounds
09/30/2010US20100247441 Site localization and methods for monitoring treatment of disturbed blood vessels
09/30/2010US20100247434 Anti-Angiogenic Extracts from Pomegranate
09/30/2010DE102009014484A1 Substituierte Piperidine Substituted piperidines
09/29/2010EP2233561A1 Method for amplification of hematopoietic stem cell using heterocyclic compound
09/29/2010EP2233504A1 An erythropoietin mimetic peptide derivatives and its pharmaceutical salt, the preparation and uses thereof
09/29/2010EP2233501A1 Humanized anti-cd34 monoclonal antibody, the preparation and uses thereof
09/29/2010EP2233145A1 A dose of AVE5026 for the treatment of venous thromboembolism in patients with severe renal impairment
09/29/2010EP2233143A1 Use of idrabiotaparinux for decreasing the incidence of bleedings during an antithrombotic treatment
09/29/2010EP2231645A2 5-halogen-substituted oxindole derivatives and use thereof for treating vasopressine-dependent diseases
09/29/2010EP2231644A2 5,6-disubstituted oxindole-derivatives and use thereof for treating vasopressine-dependent diseases
09/29/2010EP2231643A1 Amidomethyl-substituted oxindole derivatives and the use thereof for the treatment of vasopressin-dependent illnesses
09/29/2010EP2231171A2 Compositions and methods for increasing iron absorption
09/29/2010EP1095274B1 Trifunctional reagent for conjugation to a biomolecule
09/29/2010CN1872285B Drop pills of Chinese traditional medicine, and preparation method
09/29/2010CN1872261B Drop pills of fine powder of dragons blood, and preparation method
09/29/2010CN1872064B Drop pills of piperazine ferulic acid, and preparation method
09/29/2010CN1864744B Pharmaceutical preparation containing urate oxidase
09/29/2010CN101849006A Improved antibody molecule
09/29/2010CN101848894A New anticoagulant compounds, pharmaceutical compositions on their basis to treat thrombotic conditions, and plasma-substituting solution to correct hypercoagulation defects of hemodilution
09/29/2010CN101845446A Fad4, fad5, fad5-2, and fad6, novel fatty acid desaturase family members and uses thereof
09/29/2010CN101843903A Method for inhibiting activation of platelet and application thereof
09/29/2010CN101843895A Cytokine receptor ZCYTOR17 multimers
09/29/2010CN101843891A Blood tonifying compound
09/29/2010CN101843889A Medicament for treating lymphedema and venous edema and application thereof
09/29/2010CN101843876A Chinese medicinal composition for preventing renal cell apoptosis and anemia caused by cis-platinum (DDP) and preparation method thereof
09/29/2010CN101843791A Chinese medicinal health-care preparation for sub-health people, brain workers and middle-aged and elderly people
09/29/2010CN101843765A Medicament for treating edema of limbs and trunks and application thereof
09/29/2010CN101843649A Chinese medicament for treating colporrhagia and preparation method thereof
09/29/2010CN101843648A Ixeris sonchifolia hance medicinal preparations for treating coronary disease and cerebral thrombosis
09/29/2010CN101843636A Preparation process of non-PVC-soft-bag-packaged hemofiltration replacement liquid and product
09/29/2010CN101843634A Biocompatible dialysis fluids containing icodextrins
09/29/2010CN101843627A Application of dihydrophenanthrene glycoside compound in preparing medicines for preventing and curing cardiovascular and cerebrovascular diseases
09/29/2010CN101843594A Alprostadil freeze-dried emulsion for injection and preparation method thereof
09/29/2010CN101524190B Disease preventing and curing medicinal mouth-muffle and medicinal composition
09/29/2010CN101332211B Leech extract and preparation method and use thereof
09/29/2010CN101318992B Complete-basic amino acid oligopeptide, copper complex, synthesis method, self-assembly and application thereof
09/29/2010CN101278926B Applications of iron chelator in preparation of medicament for preventing or curing hemorrhagic cerebrovascular disease and chronic hydrocephalus after craniocerebral injury
09/29/2010CN101274931B Preparing process for rupatadine
09/29/2010CN101244163B Tableland yak blood capsule and preparation thereof
09/29/2010CN101244060B Leonurus heterophyllus alkaloid composition
09/29/2010CN101129469B Traditional Chinese medicine composition for preventing and controlling cardiovascular disease
09/29/2010CN101068812B Efficient synthesis of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones
09/28/2010US7803954 Mandelic acid derivatives and their use as thrombin inhibitors
09/28/2010US7803911 preparing a stable dried composition of blood factor product containing a stabilizing amount of trehalose in the absence of a stabilizing amount of albumin
09/28/2010US7803840 Use of certain dialkyl fumarates for the preparation of pharmaceutical preparations for use in transplantation medicine or for the therapy of autoimmune diseases and said compositions in the form of micro-tablets or pellets; dimethyl fumarate
09/28/2010US7803835 Substituted acetic acid derivatives
09/28/2010US7803772 Administering a polypeptide having at least one of anti-angiogenic, tumor-suppressive, or anti-migratory activity, but does not have stimulation of cell proliferation activity
09/28/2010US7803562 Method for screening human intestinal Npt2B modulatory agents
09/28/2010CA2474430C A combination of a thrombolytic agent and levosimendan for the treatment of acute myocardial infarction
09/28/2010CA2386417C Phenyl- and pyridyl-tetrahydropyridines having tnf-inhibiting activity
09/28/2010CA2383257C Substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benozopyrans
09/28/2010CA2376304C Amide substituted imidazoquinolines
09/23/2010WO2010108028A2 Compositions comprising cyclic amp enhancers and/or ep ligands, and methods of preparing and using the same
09/23/2010WO2010108016A2 Compositions and methods for sparing muscle in renal insufficiency and during hemodialysis
09/23/2010WO2010106988A1 Amide derivative
09/23/2010WO2010106871A1 Osmotic pressure-controlling agent
09/23/2010WO2010106519A1 A dose of ave5026 for the treatment of venous thromboembolism in patients with severe renal impairment
09/23/2010WO2010105342A1 Transdermal pharmaceutical preparation and administration of tirofiban
09/23/2010WO2010022383A3 Crosslinked cation exchange polymers, compositions and use in treating hyperkalemia
09/23/2010US20100241201 Indwelling heat exchange catheter and method of using same
09/23/2010US20100240742 Anti-angiogenic compositions and methods of use
09/23/2010US20100240736 Novel Compounds for the Treatment or Alleviation of Edema, and Methods for their Use
09/23/2010US20100240716 Thiadiazoline derivative
09/23/2010US20100240683 Combination therapy, composition and methods for the treatment of cardiovascular disorders
09/23/2010US20100240677 Compounds as PDE IV and TNF Inhibitors
09/23/2010US20100240654 Hydrazide derivatives
09/23/2010US20100240650 Substituted pyrrolines as kinase inhibitors
09/23/2010US20100240610 Quinolone based compounds exhibiting prolyl hydroxylase inhibitory activity, and compositions, and uses thereof
09/23/2010US20100240584 Nematode-extracted serine protease inhibitors and anticoagulant proteins
1 ... 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 ... 671